Skip to main content
Clinical Trials/NCT02996565
NCT02996565
Completed
Not Applicable

Pragmatic Trial Comparing Telehealth Care and Optimized Clinic-Based Care for Uncontrolled High Blood Pressure

HealthPartners Institute1 site in 1 country3,072 target enrollmentNovember 15, 2017
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
HealthPartners Institute
Enrollment
3072
Locations
1
Primary Endpoint
Change in Systolic Blood Pressure Between Baseline and 12 Months (mm Hg)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Clinics in the study are randomized to offer one of the two treatment models to participants with uncontrolled hypertension.

The investigators aim to determine a) whether one model is more effective than the other for lowering patient's blood pressure and b) which model patients prefer.

Detailed Description

The objectives of the study are: Aim 1: Compare the effects of two evidence-based strategies on lowering blood pressure and other outcomes important to patients: best-practice clinic-based care and home-based telehealth care. * Hypothesis 1.1: Compared with patients in clinics assigned to clinic-based care, patients in clinics assigned to telehealth care will have a 5 mm Hg greater change in systolic blood pressure over 12 months of follow-up. * Hypothesis 1.2: Compared with patients in clinics assigned to clinic-based care, patients in clinics assigned to telehealth care will report: a) fewer treatment side effects; b) better ratings of patient experience of hypertension care; and c) higher self-monitoring rates and confidence in self-care. Aim 2: Conduct an evaluation of the reach, adoption, implementation, and maintenance of the telehealth care and clinic-based care interventions using a mixed-methods approach supported by the RE-AIM framework and the Consolidated Framework for Implementation Research (CFIR).

Registry
clinicaltrials.gov
Start Date
November 15, 2017
End Date
June 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hypertension diagnosis code in medical record, twice in last 24 months
  • Attends study clinic for primary care visit within study period with uncontrolled blood pressure
  • Systolic blood pressure \>=150 mm Hg or Diastolic blood pressure \>=95 mm Hg at current visit
  • Systolic blood pressure \>=150 mm Hg or Diastolic blood pressure \>=95 mm Hg at most recent previous visit

Exclusion Criteria

  • Pregnancy
  • End Stage Kidney Disease
  • Patients in hospice care and patients who permanently reside in a nursing home

Outcomes

Primary Outcomes

Change in Systolic Blood Pressure Between Baseline and 12 Months (mm Hg)

Time Frame: Trajectory over 12 months

Change in systolic BP, collected from medical records

Secondary Outcomes

  • Change in Diastolic BP Between Baseline and 12 Months (mm Hg)(Trajectory over 12 months)
  • Number of Participants Who Reporting Monitoring BP at Least 2 Times Per Week at Six Months Follow-up(Baseline to 6 months)
  • Number of Participants Who Report High Level of Satisfaction With Hypertension Care at Six Months.(Baseline to 6 months)
  • Number of Participants Who Are Current Smokers at Twelve Months(Baseline to 12 months)
  • Number of Participants Reporting Cough as a Side Effect of Antihypertensive Medications at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Dizziness as a Side Effect of Antihypertensive Medication at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Frequent Urination as a Side Effect of Antihypertensive Medication at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Leg/Foot Swelling as a Side Effect of Antihypertensive Medication at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Sexual Symptoms as a Side Effect of Antihypertensive Medication at Six Months(Baseline to 6 months)
  • Number of Participants Who Report Physical Activity as Helpful for BP Self-management at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Tiredness as a Side Effect of Antihypertensive Medication at Six Months(Baseline to 6 months)
  • Number of Participants Who Report Decreasing Salt as Helpful for BP Self-management at Six Months(Baseline to 6 months)
  • Number of Participants Who Report Limiting Alcohol as Helpful for BP Self-management at Six Months(Baseline to 6 months)
  • Number of Participants Who Report Reducing Stress as Helpful for BP Self-management at Six Months(Baseline to 6 months)
  • Number of Participants Who Report Watching Weight as Helpful for BP Self-management at Six Months(Baseline to 6 months)
  • Number of Participants Identifying Clinic Visits as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Identifying Cost of Care or Medications as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Increasing Physical Activity as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Lifestyle Changes as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Measuring BP as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Phone Visits as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Scheduling Visits as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting Time Away From Work as BP Care Burden at Six Months(Baseline to 6 months)
  • Number of Participants Reporting High Confidence in Reporting Contacting Care Team at Six Months Confidence in Managing Blood Pressure: Contact Care Team(Baseline to 6 months)
  • Number of Participants Reporting High Confidence in Keeping BP Below Target at Six Months(Baseline to 6 months)
  • Number of Participants Reporting High Confidence in Knowing BP Target Numbers at Six Months(Baseline to 6 months)
  • Number of Participants Reporting High Confidence in Measuring BP at Home at Six Months(Baseline to 6 months)
  • Number of Participants Reporting High Confidence in Taking BP Medications at Six Months(Baseline to 6 months)
  • Number of Participants With Statin Addition at 12 Months(Baseline to 12 months)

Study Sites (1)

Loading locations...

Similar Trials